|
|||||
![]() |
|
Personal care company Edgewell Personal Care (NYSE:EPC) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 3.1% year on year to $580.7 million. Its non-GAAP profit of $0.87 per share was 4.7% below analysts’ consensus estimates.
Is now the time to buy EPC? Find out in our full research report (it’s free).
Edgewell Personal Care’s first quarter results reflected mixed performance across its portfolio, with particular challenges in North America offset by resilience in international markets. Management attributed the sales decline primarily to a slower-than-anticipated recovery in its U.S. Fem Care business and a sluggish start to the domestic sun care season, which CEO Rod Little linked to poor weather and ongoing consumer uncertainty. Despite these headwinds, the company pointed to continued growth in international markets and cited operational improvements, including productivity savings and supply chain efficiencies, as positive contributors to the quarter.
Looking ahead, Edgewell’s updated guidance incorporates softer category consumption trends and rising cost pressures, especially from tariffs and increased brand investment in North America. CFO Fran Weissman emphasized that the revised outlook assumes only low single-digit growth for U.S. sun care and acknowledges ongoing headwinds from tariffs, which could impact costs by up to 4% of total cost of goods sold. Management remains focused on executing brand campaigns and productivity initiatives, with Dan Sullivan, Chief Operating Officer, noting, “We are incrementally investing in promotion and retail activation in the third quarter, particularly behind women’s shave and sun care, to capture upcoming seasonal demand.”
Management identified weaker U.S. category performance, tariff-related cost pressures, and targeted brand investments as the main factors shaping quarterly results and strategic priorities.
Edgewell’s outlook for the remainder of the year is shaped by cautious consumer trends, tariff uncertainties, and planned brand investments in North America.
In coming quarters, StockStory analysts will monitor (1) the effectiveness of increased North America brand investment in reversing category declines, (2) the company’s ability to mitigate ongoing tariff and cost pressures through sourcing and pricing actions, and (3) whether international growth and innovation can offset domestic headwinds. Progress on inventory management and working capital will also be key to sustaining free cash flow targets.
Edgewell Personal Care currently trades at a forward P/E ratio of 8.1×. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free).
The market surged in 2024 and reached record highs after Donald Trump’s presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025.
While the crowd speculates what might happen next, we’re homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver’s seat and build a durable portfolio by checking out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
Jun-10 | |
Jun-05 | |
May-15 | |
May-15 | |
May-15 | |
May-09 | |
May-08 | |
May-07 | |
May-07 | |
May-07 | |
May-07 | |
May-07 | |
May-07 | |
May-06 | |
May-06 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite